This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pour, P. Articles by Salmasi, S. Search for Related Content PubMed PubMed Citation Articles by Pour, P. Articles by Salmasi, S.

Carcinogenicity of N-Nitrosomethyl(2-oxopropyl)amine in Syrian Hamsters¹

Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, Nebraska 68105

7-Methylguanine was found in hydrolysates of liver and pancreas DNA from Syrian golden hamsters given a single dose of N-[1-¹⁴C]nitrosobis(2-oxopropyl)amine (BOP). This led us to examine the carcinogenicity of a potential methylating metabolite of BOP, N-nitrosomethyl(2-oxopropyl)amine (MOP). MOP was found to be a potent pancreatic carcinogen by either single or weekly s.c. injections. A single MOP treatment (25 mg/kg body weight) induced ductular adenomas and/or adenocarcinomas in 80% of the hamsters. A higher incidence of these neoplasms was found in 93% and 87% of animals receiving, respectively, 3.5 and 1.75 mg MOP per kg body weight weekly for life. However, the lower dose (0.87 mg/kg body weight) was less effective, resulting in a 33% tumor incidence. Compared with the known potent pancreatic carcinogen BOP, MOP seemed to have a greater affinity for the pancreas since considerably lower doses were required to induce similar incidences of equivalent pancreatic tumors. Like BOP, MOP caused tumors of the liver (7 to 100% incidence), kidneys (7 to 80% incidence), and vascular system (7 to 27% incidence). However, in contrast to BOP, which was noncarcinogenic to the upper respiratory tract, MOP-treated animals developed a high incidence of nasal cavity tumors (40% after a single treatment and 27 to 100% after weekly injections). The mutagenesis studies using hamster liver cell-mediated V79 cells confirmed the stronger effect of MOP compared to BOP. The assumption that MOP might be a proximate carcinogenic metabolite of BOP could not be substantiated by our methods for determining the in vivo and in vitro metabolites of BOP.

¹ Supported by Grant NO1-R26-CA-20198 from the National Cancer Institute National Pancreatic Cancer Project and NIH Contract NO1-CP-33278 from the National Cancer Institute.

² To whom requests for reprints should be addressed.

Received 10/29/79. Accepted 7/ 2/80.

This article has been cited by other articles:

				M Tascilar, B P van Rees, P D J Sturm, G N J Tytgat, R H Hruban, S N Goodman, F M Giardiello, G J A Offerhaus, and A C Tersmette Pancreatic cancer after remote peptic ulcer surgery J. Clin. Pathol., May 1, 2002; 55(5): 340 - 345. [Abstract] [Full Text] [PDF]